JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for AGIOS PHARMACEUTICALS, INC. · rare disease focused biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $10,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Issues related to prescription drugs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem